Clinical Trial

Omega-3, Autism Spectrum Disorder (ASD)

Name: Omega-3, Autism Spectrum Disorder (ASD) — clinical trial record (NCT07365553)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: OMeASD

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated January 26, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).

Trial Details

NCT Number	NCT07365553
Lead Sponsor	China Medical University Hospital
Conditions	ASD
Enrollment	50 participants
Start Date	2022-07-15
Primary Completion	2026-06-30 (estimated)
Study Completion	2026-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-26